GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Healius Ltd (OTCPK:PHCRF) » Definitions » Shares Outstanding (EOP)

PHCRF (Healius) Shares Outstanding (EOP) : 726 Mil (As of Dec. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Healius Shares Outstanding (EOP)?

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Healius's shares outstanding for the quarter that ended in Dec. 2024 was 726 Mil.

Healius's quarterly shares outstanding increased from Jun. 2024 (726 Mil) to Dec. 2024 (726 Mil). It means Healius issued new shares from Jun. 2024 to Dec. 2024 .

Healius's annual shares outstanding increased from Jun. 2023 (615 Mil) to Jun. 2024 (726 Mil). It means Healius issued new shares from Jun. 2023 to Jun. 2024 .


Healius Shares Outstanding (EOP) Historical Data

The historical data trend for Healius's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Healius Shares Outstanding (EOP) Chart

Healius Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 672.81 672.81 614.97 615.32 726.10

Healius Semi-Annual Data
Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 615.29 615.32 726.07 726.10 726.13

Competitive Comparison of Healius's Shares Outstanding (EOP)

For the Diagnostics & Research subindustry, Healius's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Healius's Shares Outstanding (EOP) Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Healius's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Healius's Shares Outstanding (EOP) falls into.


;
;

Healius Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.


Healius  (OTCPK:PHCRF) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Healius Shares Outstanding (EOP) Related Terms

Thank you for viewing the detailed overview of Healius's Shares Outstanding (EOP) provided by GuruFocus.com. Please click on the following links to see related term pages.


Healius Business Description

Traded in Other Exchanges
Address
161 Castlereagh Street, Level 22, Sydney, NSW, AUS, 2000
Healius is Australia's second-largest pathology provider and third-largest diagnostic imaging provider, though the latter business is set to be sold in early 2025. Pathology and imaging revenue is almost entirely earned via the public health Medicare system. Healius typically earns approximately 75% of revenue from pathology and 25% from diagnostic imaging.

Healius Headlines

From GuruFocus

Half Year 2021 Healius Ltd Earnings Call Transcript

By GuruFocus Research 03-29-2024

Healius Ltd Annual Shareholders Meeting Transcript

By GuruFocus Research 03-29-2024

Full Year 2020 Healius Ltd Earnings Call Transcript

By GuruFocus Research 03-29-2024

Half Year 2025 Healius Ltd Earnings Call Transcript

By GuruFocus News 02-21-2025

David Herro Comments on Primary Health Care

By Holly LaFon Holly LaFon 04-11-2016

Full Year 2023 Healius Ltd Earnings Call Transcript

By GuruFocus Research 03-29-2024

David Herro Comments on Healius

By Sydnee Gatewood Sydnee Gatewood 01-09-2020